Dec 22, 2015 by Brian FeroldiThe Best 3 Biotech Stocks for 2016Each of these biotech stocks looks poised to put up impressive growth next year.
Dec 21, 2015 by Brian FeroldiThe Best CVS Health Corporation Headlines in 2015A lot happened in 2015 at the nation's largest pharmacy chain. Here are the updates investors need to be aware of.
Dec 21, 2015 by Brian Feroldi, Selena Maranjian, and Sean WilliamsTop Biotech Stocks to Buy in 2016Our Motley Fool contributors named these three biotech stocks as their top ideas heading into 2016.
Dec 20, 2015 by Brian Feroldi, Selena Maranjian, Sean Williams, Brian Stoffel, and Jason Hall5 Stocks We're Staying Away From in 2016If you want to do well in the markets, it helps to know which stocks you shouldn't buy.
Dec 20, 2015 by Brian Feroldi3 Predictions of Where the Dow Jones Industrial Average Could Finish in 2016 (and Why They're All Probably Wrong)Will the Dow Jones Industrial Average come roaring back to life in 2016, or will the year prove to be another bad one for the markets? Three Motley Fool contributors weigh in.
Dec 20, 2015 by Brian Feroldi, Selena Maranjian, Sean Williams, Dan Caplinger, and Jason Hall5 Smart Ways to Use Your Holiday Bonus in 2015Were you lucky enough to receive a holiday bonus this year? Here are five smart ways to use the money.
Dec 19, 2015 by Brian FeroldiLast Week's Best Healthcare ETFIn the healthcare sector, this ETF was the top performer in the group. Here's why.
Dec 19, 2015 by Brian FeroldiThe Best Regeneron Pharmaceuticals, Inc Headlines in 2015It was another great year to be invested in this high-flying winner.
Dec 18, 2015 by Brian FeroldiMannKind Overcomes 1 Hurdle -- but Bigger Challenges AwaitManagement lets us know that one major barrier to Afrezza adoption is no longer an issue, but odds are still long that the company can succeed.
Dec 17, 2015 by Brian FeroldiMartin Shkreli -- "The Most Hated Man in America" -- Is in Handcuffs. Here's Why.Biotech CEO Martin Shkreli was arrested today on charges of securities fraud.
Dec 16, 2015 by Brian FeroldiWhy Advaxis, Inc Shares are Skyrocketing TodayNews of the FDA lifting its clinical holds on the company's IND applications sends shares soaring.
Dec 15, 2015 by Brian FeroldiDoes Novo Nordisk's New Diabetes Drug Spell Doom for MannKind Corp?Novo Nordisk just filed a new application for a fast-acting insulin, and if it gains approval, it could put a world of hurt on Afrezza.
Dec 14, 2015 by Brian FeroldiWhy Atara Biotherapeutics Inc. Shares Are Getting Mauled TodayDisappointing news from a phase 2 clinical trial has investors running for the hills.
Dec 13, 2015 by Brian FeroldiWill Anyone Catch MannKind's Hail Mary?Potential news of a new partnership might send shares of MannKind temporarily higher, but don't expect it to be enough to turn the drugmaker's fortunes around.
Dec 13, 2015 by Brian Feroldi, Selena Maranjian, and Brian Stoffel3 Reasons It's a Mistake to Wait Until 70 to Claim Social SecurityThinking about waiting until age 70 to make a claim? Our contributors offer up three reasons that may be a mistake.
Dec 13, 2015 by Brian FeroldiLast Week's Best Healthcare ETFIt was an ugly week for the market and healthcare ETFs were hit hard, yet this one ETF once again proved itself to be the top performer of the bunch.
Dec 11, 2015 by Brian Feroldi, Selena Maranjian, Sean Williams, Dan Caplinger, Brian Stoffel, Jason Hall, and Matt Frankel, CFP7 Unique Ways to Save MoneyLooking for a few ways to save more money? Our top contributors think that these 7 ideas are worthy of consideration.
Dec 10, 2015 by Brian FeroldiNovember's Best Healthcare ETFMany exchange traded funds that focus on the healthcare sector performed well in November, but one fund in particular was a standout.
Dec 9, 2015 by Brian FeroldiNovember's Worst Healthcare ETF This popular healthcare ETF lagged the market's returns in November. Here's why.
Dec 9, 2015 by Brian FeroldiWhy Organovo Holdings Inc Jumped 12% in NovemberA mixed quarterly report and a "best of what's new" label sends shares of the beaten-down 3D printer higher.
